Benchmark Upgrades Codexis, Inc. (CDXS) to Buy, 'New Enzyme Coming Into Its Own'

Go back to Benchmark Upgrades Codexis, Inc. (CDXS) to Buy, 'New Enzyme Coming Into Its Own'
CODEXIS (NASDAQ: CDXS) Delayed: 1.62 +0.02 (1.25%)
Previous Close $1.60    52 Week High $5.25 
Open $1.61    52 Week Low $2.93 
Day High $1.66    P/E N/A 
Day Low $1.59    EPS $-1.25 
Volume 355,467